Lactobacillus salivarius WB21--containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial.

@article{Suzuki2014LactobacillusSW,
  title={Lactobacillus salivarius WB21--containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial.},
  author={Nao Suzuki and Masahiro Yoneda and Kazunari Tanabe and Akie Fujimoto and Kosaku Iha and Kei Seno and Kazuhiko Yamada and Tomoyuki Iwamoto and Yosuke Masuo and Takao Hirofuji},
  journal={Oral surgery, oral medicine, oral pathology and oral radiology},
  year={2014},
  volume={117 4},
  pages={462-70}
}
OBJECTIVE This study evaluated the effect of probiotic intervention using lactobacilli on oral malodor. STUDY DESIGN We conducted a 14-day, double-blind, placebo-controlled, randomized crossover trial of tablets containing Lactobacillus salivarius WB21 (2.0 × 10(9) colony-forming units per day) or placebo taken orally by patients with oral malodor. RESULTS Organoleptic test scores significantly decreased in both the probiotic and placebo periods compared with the respective baseline scores… CONTINUE READING
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…